| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P50 | author | Steve N Caritis | Q57051819 |
| Ben W. Mol | Q61861924 | ||
| P2093 | author name string | E Thom | |
| A C Lim | |||
| D Rouse | |||
| T J Garite | |||
| C A Combs | |||
| E Schuit | |||
| A T Tita | |||
| Global Obstetrics Network (GONet) collaboration | |||
| K Maurel | |||
| P2860 | cites work | Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis | Q44997517 |
| Infant and perinatal outcomes of triplet pregnancy in Auckland: better than expected? | Q45183925 | ||
| Twins and triplets: the effect of plurality and growth on neonatal outcome compared with singleton infants | Q46119842 | ||
| Triplet pregnancies--a three-decade perspective: do we fare better? | Q46319734 | ||
| Trends in incidence and mortality for triplets in Norway 1967-2006: the influence of assisted reproductive technologies | Q46331528 | ||
| Comparative study of perinatal outcome of dichorionic and trichorionic iatrogenic triplets | Q46342477 | ||
| Perinatal outcome of spontaneously conceived triplet pregnancies in relation to chorionicity | Q46343233 | ||
| Maternal and neonatal outcome of 93 consecutive triplet pregnancies with 71% vaginal delivery | Q46346816 | ||
| Routine cervical cerclage in higher order multiple gestation -- does it prolong the pregnancy? | Q46351624 | ||
| Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial | Q46833418 | ||
| Prevention of spontaneous preterm birth: the role of sonographic cervical length in identifying patients who may benefit from progesterone treatment | Q46978677 | ||
| How should randomised trials including multiple pregnancies be analysed? | Q47206873 | ||
| Vaginal progesterone for the prevention of preterm birth in twin gestations: a randomized placebo-controlled double-blind study. | Q47546837 | ||
| Vaginal progesterone to prevent preterm birth in multiple pregnancy: a randomized controlled trial | Q47552483 | ||
| Neonatal outcomes in triplet pregnancies: assisted reproduction versus spontaneous conception. | Q47853396 | ||
| Obstetric complications and perinatal outcome in triplet pregnancies | Q47857222 | ||
| Prevention of preterm delivery by 17 alpha-hydroxyprogesterone caproate in asymptomatic twin pregnancies with a short cervix: a randomized controlled trial. | Q54259748 | ||
| A Trial of 17 Alpha-Hydroxyprogesterone Caproate to Prevent Prematurity in Twins | Q59584875 | ||
| Prevention of preterm delivery in twin gestations (PREDICT): a multicenter, randomized, placebo-controlled trial on the effect of vaginal micronized progesterone | Q61848068 | ||
| Progesterone protects fetal chorion and maternal decidua cells from calcium-induced death | Q79903385 | ||
| Prenatal diagnosis and obstetric outcomes in triplet pregnancies in relation to chorionicity | Q81670262 | ||
| 17-hydroxyprogesterone caproate for twin pregnancy: a double-blind, randomized clinical trial | Q83534547 | ||
| 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial | Q84807780 | ||
| Progestogen safety in multiple gestations: application of the Bradford Hill criteria | Q86526400 | ||
| The effectiveness of multifetal pregnancy reduction in trichorionic triplet gestation | Q87759948 | ||
| Hospitalisation and bed rest for multiple pregnancy | Q24234262 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate | Q28178563 | ||
| Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice | Q28654984 | ||
| Births: final data for 2011. | Q30833850 | ||
| Effectiveness of progestogens to improve perinatal outcome in twin pregnancies: an individual participant data meta-analysis | Q30844080 | ||
| Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement | Q30940208 | ||
| Investigating heterogeneity in an individual patient data meta-analysis of time to event outcomes | Q30981851 | ||
| Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. | Q31016826 | ||
| Revisiting reproduction: Prematurity and the puzzle of progesterone resistance | Q33349031 | ||
| Meta-analysis of individual participant data: rationale, conduct, and reporting | Q33530020 | ||
| Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data | Q34143212 | ||
| Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study | Q34178184 | ||
| Pharmacokinetics of 17-hydroxyprogesterone caproate in multifetal gestation | Q34629600 | ||
| Progesterone and the risk of preterm birth among women with a short cervix | Q34658686 | ||
| Prevention of preterm birth in triplets using 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial | Q34925836 | ||
| Reducing the incidence of twins and triplets | Q35131937 | ||
| Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? | Q36017145 | ||
| Relationship between 17-hydroxyprogesterone caproate concentrations and gestational age at delivery in twin gestation | Q36356909 | ||
| 17 alpha-hydroxyprogesterone caproate to prevent prematurity in nulliparas with cervical length less than 30 mm. | Q36357070 | ||
| Temporal changes in rates of stillbirth, neonatal and infant mortality among triplet gestations in the United States | Q36469479 | ||
| Review: a gentle introduction to imputation of missing values | Q36596050 | ||
| Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation | Q36650851 | ||
| The effect of plurality and gestation on the prevention or postponement of infant mortality: 1989-1991 versus 1999-2001 | Q36758519 | ||
| Perinatal and neonatal outcomes of triplet gestations based on placental chorionicity | Q37445679 | ||
| Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth | Q37588374 | ||
| Maternal and neonatal outcome in triplet, quadruplet and quintuplet gestations following ART: a 11-year study | Q38094632 | ||
| Healthcare expenses associated with multiple vs singleton pregnancies in the United States | Q38163126 | ||
| The use of vaginal natural progesterone for prevention of preterm birth in IVF/ICSI pregnancies | Q38858013 | ||
| Terbutaline pump tocolysis in high-order multiple gestation | Q41668541 | ||
| Failure of 17-hydroxyprogesterone to reduce neonatal morbidity or prolong triplet pregnancy: a double-blind, randomized clinical trial | Q42917966 | ||
| Progesterone does not prevent preterm births in women with twins | Q43294921 | ||
| Medication safety is still an issue in obstetrics 50 years after the Kefauver–Harris amendments: the case of progestogens | Q43725081 | ||
| Increased doses of vaginal progesterone for the prevention of preterm birth in twin pregnancies: a randomised controlled double-blind multicentre trial. | Q43917330 | ||
| A randomised controlled double-blind clinical trial of 17-hydroxyprogesterone caproate for the prevention of preterm birth in twin gestation (PROGESTWIN): evidence for reduced neonatal morbidity | Q44037735 | ||
| Prophylactic cerclage in the management of triplet pregnancies | Q44085629 | ||
| P433 | issue | 5 | |
| P921 | main subject | maternal health | Q6786626 |
| P304 | page(s) | 682-690 | |
| P577 | publication date | 2015-12-10 | |
| P1433 | published in | BJOG: an International Journal of Obstetrics and Gynaecology | Q15724571 |
| P1476 | title | 17-Hydroxyprogesterone caproate in triplet pregnancy: an individual patient data meta-analysis | |
| P478 | volume | 123 |
| Q47351239 | Evaluating progestogens for prevention of preterm birth international collaborative (EPPPIC) individual participant data (IPD) meta-analysis: protocol. |
| Q46301851 | Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy. |
| Q31149131 | Real-time continuous glucose monitoring in type 1 diabetes: a systematic review and individual patient data meta-analysis. |
Search more.